111
Participants
Start Date
October 31, 2025
Primary Completion Date
October 31, 2027
Study Completion Date
March 31, 2028
monoclonal CD-20 antibodies
Treatment with monoclonal CD-20 antibodies 6 months before or during pregnancy
No Drug
No medication
Other treatment
Any other immune modulating treatment
Academic specialist center, Center for Neurology, Stockholm
The Swedish Research Council
OTHER_GOV
Haukeland University Hospital
OTHER
Karolinska Institutet
OTHER
Region Stockholm
OTHER_GOV